Evidence map›Paper›PMID 42189819›Full record

ArticlePLoS neglected tropical diseases2026

The atypical dual-specificity protein phosphatase (DUSP)/kinatase of Leishmania infantum modulates infectivity, oxidative stress response and antimonial resistance.

Juliana Martins Ribeiro, Giovanna Ferreira da Fonseca, Milena Airi Kimura Anbo, Karla Ferreira Costa, Amanda Cristina Silva de Oliveira, Karine Ferreira Lopes, Mariza Gabriela Faleiro de Moura Lodi Cruz, Héllida Marina Costa-Silva, Ana Maria Murta Santi, Silvane Maria Fonseca Murta

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juliana Martins RibeiroFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Giovanna Ferreira da FonsecaFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Milena Airi Kimura AnboFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Karla Ferreira CostaFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Amanda Cristina Silva de OliveiraFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Karine Ferreira LopesFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Mariza Gabriela Faleiro de Moura Lodi CruzFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Héllida Marina Costa-SilvaFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
Ana Maria Murta SantiFundação Oswaldo Cruz - Fiocruz, Instituto Carlos Chagas, Curitiba, Paraná, Brazil.
Silvane Maria Fonseca MurtaFundação Oswaldo Cruz - Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0002-8523-2155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dual-specificity protein phosphatases (DUSPs) are key modulators of mitogen-activated protein kinase (MAPK) signaling pathways that regulate cellular proliferation, differentiation, and stress adaptation. Although extensively characterized in higher eukaryotes, the functional roles of DUSPs in Leishmania remain poorly understood. In this study, we investigated the function of an atypical dual-specificity phosphatase/kinatase (LINF_340027100) in Leishmania infantum using CRISPR/Cas9-mediated genome editing. Repeated attempts to generate DUSP-null mutants were unsuccessful, and episomal complementation prior to chromosomal disruption did not permit deletion of the endogenous locus, suggesting that DUSP is essential for promastigote viability. To investigate DUSP function, we generated parasite lines with altered gene expression, including a heterozygous knockout (Li DUSP+/-) and an episomal overexpressor (Li WT + pIR1_SAT-DUSP). Modulation of DUSP expression resulted in pronounced alterations in parasite morphology, cell-cycle progression, differentiation, and intracellular proliferation in macrophages. The Li DUSP+/- line exhibited a twofold reduction in transcript abundance and maintained normal growth kinetics, but displayed elongated morphology, increased flagellar length, and a reduced G0/G1 population with concomitant S-phase accumulation. In addition, Li DUSP+/- parasites showed decreased tolerance to hydrogen peroxide, being 1.5- and 5.7-fold more sensitive in promastigote and intracellular amastigote forms, respectively. Conversely, the DUSP-overexpressing line exhibited a 2.3-fold increase in DUSP transcript levels, accompanied by modest impairment of promastigote proliferation, rounded morphology, altered cell-cycle distribution, and increased resistance to trivalent antimony, with 2.6- and 3.1-fold higher resistance observed in promastigote and intracellular amastigote forms, respectively. Both mutant lines showed reduced intracellular proliferation at 72 h post-infection. Transcript level analysis revealed altered expression of MAPK1, MAPK3, and MAPK10 in both promastigote and axenic amastigote-like forms, supporting a functional link between DUSP activity and MAPK signaling homeostasis. Together, these findings identify DUSP as a key regulator of parasite biology that integrates MAPK signaling with oxidative stress response, differentiation, and antimony susceptibility in L. infantum. This study provides the first functional characterization of this atypical DUSP/kinatase in Leishmania and highlights its potential as a target for therapeutic intervention.

Indexed as

Drug ResistanceDual-Specificity PhosphatasesLeishmania infantumOxidative StressProtozoan ProteinsAnimalsHumansLeishmaniasis, VisceralMacrophagesMiceDual-Specificity PhosphatasesProtozoan Proteins

Identifiers

PMID42189819
PMCPMC13210143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.